Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Praxis Precision Medicines, Inc.’s reported figures.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
FAQ
- What is Praxis Precision Medicines, Inc.'s EBIT?
- Praxis Precision Medicines, Inc. (PRAX) reported EBIT of -$96.9M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s EBIT changed year-over-year?
- Praxis Precision Medicines, Inc.'s EBIT decreased by 27.4% year-over-year, from -$76.07M to -$96.9M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s EBIT has grown at a 18.2% compound annual growth rate (CAGR), from -$167.33M to -$326.2M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Praxis Precision Medicines, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude